Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Alimera Sciences, Inc.

Alimera Sciences, Inc. (ALIM) Stock Overview

Explore Alimera Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ALIM●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$5.54
$0.010(0.18%)
U.S. Market is Open · 13:55

Alimera Sciences, Inc. (ALIM)

Meyka AI Score

Z

Key Financials

Market Cap301.3M
P/E Ratio-7.01
EPS (TTM)$1.05
ROE-1.59%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.34

ALIM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Alimera Sciences, Inc. (NASDAQ: ALIM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Alimera Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ALIM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $4.34 for the NASDAQ listing.

Key metrics behind Alimera Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -7.01 and a market capitalization of 301.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ALIM on the NASDAQ.

Price Performance (NASDAQ: ALIM)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-1.07%
6-Month Change
57.39%
Year-to-Date (YTD) Change
35.78%
1-Year Change
110.65%
3-Year Change
27.06%
5-Year Change
-5.20%
All-Time (Max) Change
-96.64%

Contact Information

https://alimerasciences.eu
678 990 5740
6310 Town Square, Alpharetta, GA, 30005

Company Facts

1,540 Employees
IPO DateNov 4, 2019
CountryUS

Frequently Asked Questions